Geron is a clinical-stage biopharmaceutical company focused on the development of a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. Telomerase is an enzyme that enables cancer cells, including malignant progenitor cells, to maintain telomere length, which provides them with the capacity for limitless, uncontrolled proliferation. Imetelstat is designed to be an oligonucleotide that targets and binds with high affinity to the active site of telomerase, thereby directly inhibiting telomerase activity and impeding malignant cell proliferation.

Employee Rating

2.8More
TypePublic
HQMenlo Park, US
Founded1990
Size (employees)15 (est)
Websitegeron.com
Geron was founded in 1990 and is headquartered in Menlo Park, US
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at Geron

John A. Scarlett

John A. Scarlett

President, Chief Executive Officer and Director
Olivia K. Bloom

Olivia K. Bloom

Executive Vice President, Finance, Chief Financial Officer and Treasurer
Melissa A. Kelly Behrs

Melissa A. Kelly Behrs

Executive Vice President, Business Development and Portfolio & Alliance Management
Andrew J. Grethlein

Andrew J. Grethlein

Executive Vice President, Development and Technical Operations
Stephen N. Rosenfield

Stephen N. Rosenfield

Executive Vice President, General Counsel and Corporate Secretary
Show more

Geron Office Locations

Geron has offices in Menlo Park and Canton
Menlo Park, (HQ)
149 Commonwealth Dr
Canton,
250 Royall St
Show all (2)
Report incorrect company information

Geron Financials and Metrics

Geron Revenue

Geron's revenue was reported to be $1.07 m in FY, 2017
USD

Net income (Q2, 2018)

(6.9m)

EBIT (Q2, 2018)

(7.2m)

Market capitalization (4-Dec-2018)

279.5m

Closing stock price (4-Dec-2018)

1.5

Cash (30-Jun-2018)

19.1m
Geron's current market capitalization is $279.5 m.
Annual
USDFY, 2013FY, 2015FY, 2016FY, 2017

Revenue

1.3m36.4m6.2m1.1m

General and administrative expense

15.6m17.8m18.8m19.3m

R&D expense

23.2m17.8m18.0m11.0m

Operating expense total

40.2m36.9m36.8m30.3m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018

Revenue

35.4m5.1m

General and administrative expense

3.5m4.0m3.9m4.1m4.0m4.3m4.8m4.5m4.7m4.7m4.4m4.8m5.3m4.2m

R&D expense

5.3m5.2m5.2m6.0m4.8m4.1m5.0m4.6m4.3m3.4m2.5m2.6m2.4m3.2m

Operating expense total

8.9m9.2m9.0m10.1m8.8m8.3m9.8m9.1m9.0m8.0m6.9m7.4m7.8m7.5m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

13.0m42.8m21.2m12.8m16.3m

Accounts Receivable

1.1m

Inventories

Current Assets

67.1m153.4m115.9m116.1m96.0m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(38.4m)(35.7m)46.0k(29.5m)(27.9m)

Depreciation and Amortization

320.0k47.0k56.0k81.0k76.0k

Inventories

Accounts Payable

(2.0m)(364.0k)(873.0k)65.0k278.0k
Quarterly
USDQ3, 2013Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

(29.1m)(9.4m)27.2m(8.8m)(8.6m)(3.6m)(7.2m)

Depreciation and Amortization

357.0k

Accounts Payable

1.2m2.4m1.2m957.0k574.0k396.0k235.0k271.0k308.0k

Cash From Operating Activities

(29.9m)
USDY, 2018

Financial Leverage

1 x
Show all financial metrics
Report incorrect company information

Geron News and Updates

Geron Reports Updated Results from Phase 2 Portion of IMerge at the 60th American Society of Hematology Annual Meeting

Data Support Initiation of Part 2, the Phase 3 portion of IMerge Data Support Initiation of Part 2, the Phase 3 portion of IMerge
Report incorrect company information

Geron Company Life and Culture

Report incorrect company information

Geron Frequently Asked Questions

  • When was Geron founded?

    Geron was founded in 1990.

  • Who are Geron key executives?

    Geron's key executives are John A. Scarlett, Olivia K. Bloom and Melissa A. Kelly Behrs.

  • How many employees does Geron have?

    Geron has 15 employees.

  • What is Geron revenue?

    Latest Geron annual revenue is $1.1 m.

  • What is Geron revenue per employee?

    Latest Geron revenue per employee is $71 k.

  • Who are Geron competitors?

    Competitors of Geron include Aptevo Therapeutics, Cleveland BioLabs and Heat Biologics.

  • Where is Geron headquarters?

    Geron headquarters is located at 149 Commonwealth Dr, Menlo Park.

  • Where are Geron offices?

    Geron has offices in Menlo Park and Canton.

  • How many offices does Geron have?

    Geron has 2 offices.